Clindamycin Palmitate Hydrochloride Oral Solution Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Heritage Pharmaceuticals Inc. is recalling one lot of Clindamycin Palmitate Hydrochloride for Oral Solution due to the presence of foreign particles and white flakes.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 25, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. initiated a voluntary recall due to the presence of foreign substance: particles and white flakes in the reconstituted bottles.
Which Products Are Affected
CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, NDC 23155-603-51. Lot #: 2411550, Exp. 2026/NOV. Distributed nationwide within the U.S. by Avet Pharmaceuticals Inc., East Brunswick, NJ 08816.
What You Should Do
Consumers should contact the recalling firm for return or refund instructions.
Why This Matters
This Class II recall affects a prescription oral antibiotic distributed nationwide.
Source
FDA recall number D-0768-2026. https://www.fda.gov
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (740 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 25, 2026.
Frequently Asked Questions
Common questions about this FDA recall.